CY1105010T1 - Πεπτιδια που λαμβανονται απο τη συνδεση (g) πρωτεϊνης του αναπνευστικου συνκυτιακου ιου - Google Patents
Πεπτιδια που λαμβανονται απο τη συνδεση (g) πρωτεϊνης του αναπνευστικου συνκυτιακου ιουInfo
- Publication number
- CY1105010T1 CY1105010T1 CY20051100274T CY051100274T CY1105010T1 CY 1105010 T1 CY1105010 T1 CY 1105010T1 CY 20051100274 T CY20051100274 T CY 20051100274T CY 051100274 T CY051100274 T CY 051100274T CY 1105010 T1 CY1105010 T1 CY 1105010T1
- Authority
- CY
- Cyprus
- Prior art keywords
- protein
- rsv
- syndicate
- respiratory
- virus
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 230000000241 respiratory effect Effects 0.000 title 1
- 108091006027 G proteins Proteins 0.000 abstract 3
- 102000030782 GTP binding Human genes 0.000 abstract 3
- 108091000058 GTP-Binding Proteins 0.000 abstract 3
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 230000002163 immunogen Effects 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 108010068327 4-hydroxyphenylpyruvate dioxygenase Proteins 0.000 abstract 1
- 206010035664 Pneumonia Diseases 0.000 abstract 1
- 206010061603 Respiratory syncytial virus infection Diseases 0.000 abstract 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000005847 immunogenicity Effects 0.000 abstract 1
- 201000009732 pulmonary eosinophilia Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5968497P | 1997-09-19 | 1997-09-19 | |
| US8486398P | 1998-05-08 | 1998-05-08 | |
| PCT/US1998/019656 WO1999014334A1 (en) | 1997-09-19 | 1998-09-17 | Peptides derived from the attachment (g) protein of respiratory syncytial virus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1105010T1 true CY1105010T1 (el) | 2010-03-03 |
Family
ID=26739056
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20051100274T CY1105010T1 (el) | 1997-09-19 | 2005-02-24 | Πεπτιδια που λαμβανονται απο τη συνδεση (g) πρωτεϊνης του αναπνευστικου συνκυτιακου ιου |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1015595B1 (enExample) |
| JP (1) | JP2001516583A (enExample) |
| KR (1) | KR100550132B1 (enExample) |
| CN (1) | CN1259422C (enExample) |
| AT (1) | ATE287957T1 (enExample) |
| AU (1) | AU751022B2 (enExample) |
| BR (1) | BR9812240A (enExample) |
| CA (1) | CA2302833C (enExample) |
| CY (1) | CY1105010T1 (enExample) |
| DE (1) | DE69828801T2 (enExample) |
| ES (1) | ES2236946T3 (enExample) |
| PT (1) | PT1015595E (enExample) |
| WO (1) | WO1999014334A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE412666T1 (de) | 2000-10-18 | 2008-11-15 | Us Gov Health & Human Serv | Zusammensetzungen und verfahren zur modulierung von rsv-infektionen und -immunität |
| AUPR520201A0 (en) * | 2001-05-23 | 2001-06-14 | Commonwealth Scientific And Industrial Research Organisation | Antiviral compounds |
| NL1019228C1 (nl) | 2001-10-25 | 2003-04-28 | Duynstee Holding B V | Verbeterd gecombineerd ophang- en verlichtingssysteem voor bijvoorbeeld schilderijen e.d. |
| US6667327B2 (en) | 2002-02-04 | 2003-12-23 | Hoffmann-La Roche Inc. | Pyridine amido derivatives |
| DE10219219A1 (de) | 2002-04-29 | 2003-11-06 | Tampoflex Gmbh | Druckanlage |
| WO2004092207A2 (en) * | 2003-04-16 | 2004-10-28 | Algonomics N.V. | Respiratory syncytial virus (rsv) peptides |
| US7368537B2 (en) * | 2003-07-15 | 2008-05-06 | Id Biomedical Corporation Of Quebec | Subunit vaccine against respiratory syncytial virus infection |
| DE602004017206D1 (de) | 2003-10-23 | 2008-11-27 | Hoffmann La Roche | Benzazepin-derivate als mao-b-hemmer |
| WO2006004874A1 (en) * | 2004-06-30 | 2006-01-12 | Wyeth Holdings Corporation | Recombinant rsv strains with altered g protein |
| US20100203071A1 (en) * | 2007-03-21 | 2010-08-12 | Norman Blais | Chimeric antigens |
| WO2009079796A1 (en) | 2007-12-24 | 2009-07-02 | Id Biomedical Corporation Of Quebec | Recombinant rsv antigens |
| WO2010149743A2 (en) | 2009-06-24 | 2010-12-29 | Id Biomedical Corporation Of Quebec | Vaccine |
| AU2010264688A1 (en) | 2009-06-24 | 2012-01-19 | Glaxosmithkline Biologicals S.A. | Recombinant RSV antigens |
| SI3178490T1 (sl) | 2009-07-15 | 2022-08-31 | Glaxosmithkline Biologicals S.A. | Sestavki proteina F RSV-ja in postopki za pripravo le-teh |
| CN103977394B (zh) * | 2009-07-17 | 2016-03-09 | 翰林大学校产学协力团 | 包含脂质体包胶的寡核苷酸和表位的免疫刺激性组合物 |
| US8846056B2 (en) | 2009-08-04 | 2014-09-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control | Anti-RSV immunogens and methods of immunization |
| SI3275892T1 (sl) | 2011-05-13 | 2020-06-30 | Glaxosmithkline Biologicals S.A. | Prefuzijski RSV F antigeni |
| CN113993884A (zh) * | 2019-04-18 | 2022-01-28 | 弗劳恩霍夫应用研究促进协会 | 抑制呼吸道合胞病毒感染的生物及合成分子 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2726577B1 (fr) * | 1994-11-07 | 1997-01-31 | Pf Medicament | Procede d'obtention d'un peptide derive du virus respiratoire syncitial, polypeptide et bacterie l'exprimant, et leurs applications a titre de medicament |
| AU722494C (en) * | 1996-06-05 | 2007-03-29 | Commonwealth Scientific And Industrial Research Organisation | Viral peptides with structural homology to protein G of respiratory syncytial virus |
| AUPO026596A0 (en) * | 1996-06-05 | 1996-06-27 | Biomolecular Research Institute Limited | Viral peptide |
-
1998
- 1998-09-17 ES ES98949392T patent/ES2236946T3/es not_active Expired - Lifetime
- 1998-09-17 JP JP2000511872A patent/JP2001516583A/ja not_active Withdrawn
- 1998-09-17 WO PCT/US1998/019656 patent/WO1999014334A1/en not_active Ceased
- 1998-09-17 CN CNB988104911A patent/CN1259422C/zh not_active Expired - Fee Related
- 1998-09-17 CA CA002302833A patent/CA2302833C/en not_active Expired - Fee Related
- 1998-09-17 PT PT98949392T patent/PT1015595E/pt unknown
- 1998-09-17 BR BR9812240-1A patent/BR9812240A/pt not_active Application Discontinuation
- 1998-09-17 AU AU95725/98A patent/AU751022B2/en not_active Ceased
- 1998-09-17 AT AT98949392T patent/ATE287957T1/de not_active IP Right Cessation
- 1998-09-17 KR KR1020007002861A patent/KR100550132B1/ko not_active Expired - Fee Related
- 1998-09-17 EP EP98949392A patent/EP1015595B1/en not_active Expired - Lifetime
- 1998-09-17 DE DE69828801T patent/DE69828801T2/de not_active Expired - Fee Related
-
2005
- 2005-02-24 CY CY20051100274T patent/CY1105010T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU751022B2 (en) | 2002-08-08 |
| BR9812240A (pt) | 2000-07-18 |
| ATE287957T1 (de) | 2005-02-15 |
| DE69828801D1 (de) | 2005-03-03 |
| JP2001516583A (ja) | 2001-10-02 |
| EP1015595A1 (en) | 2000-07-05 |
| AU9572598A (en) | 1999-04-05 |
| PT1015595E (pt) | 2005-05-31 |
| CN1322250A (zh) | 2001-11-14 |
| CA2302833C (en) | 2007-05-08 |
| DE69828801T2 (de) | 2005-07-14 |
| WO1999014334A1 (en) | 1999-03-25 |
| KR100550132B1 (ko) | 2006-02-08 |
| CA2302833A1 (en) | 1999-03-25 |
| EP1015595B1 (en) | 2005-01-26 |
| KR20010030620A (ko) | 2001-04-16 |
| ES2236946T3 (es) | 2005-07-16 |
| CN1259422C (zh) | 2006-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1105010T1 (el) | Πεπτιδια που λαμβανονται απο τη συνδεση (g) πρωτεϊνης του αναπνευστικου συνκυτιακου ιου | |
| DE69632235D1 (de) | Newcastle-Krankheitsvirus-Kombinationsimpfstoff | |
| IS4518A (is) | Nýtt lyfjaform fyrir bóluefni | |
| CY1118521T1 (el) | Συνθεση εμβολιου και μεθοδος χρησης αυτου | |
| BR9306820A (pt) | Conjugado de um antígeno fracamente imunogênico e um veículo peptideo sintetico vacina processos para melhorar a imunogenicidade de uma molecula de antigeno fracamente imunogenico e para imunizar um hospedeiro mamífero | |
| ES2150493T3 (es) | Adyuvantes para vacunas contra el virus sincitico respiratorio. | |
| MA24638A1 (fr) | Vaccin | |
| ATE392904T1 (de) | Pharmazeutische zusammensetzung zur immunstimulation und zur zubereitung von impfstoffen enthaltend ein antigen, und als adjuvantien ein immunogenes oligodesoxynukleotid und ein polykationisches polypeptid | |
| ATE209216T1 (de) | Cyclosporin-derivate mit anti-hiv-wirkung | |
| BR9201015A (pt) | Conjugado de proteina,composto,processo para preparar o conjugado,composicoes farmaceuticas e uso | |
| NO912825D0 (no) | Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper. | |
| BR9704879A (pt) | Composição de vacina e uso de um vírus cav vivo | |
| WO2002032923A3 (en) | Improved formulations using heat shock/stress protein-peptide complexes | |
| DK0491628T3 (da) | Lipopeptider inducerende cytotoksiske T-lymfocytter og deres anvendelse som vacciner | |
| CY1107620T1 (el) | Πολυ-συστατικο εμβολιο για την προστασια εναντι της παθησης που προκαλειται απο haemophilus influenzae and moraxella catarrhalis | |
| DE69415462D1 (de) | Synthetischen peptiden und impfstoffe gegen parvovirus | |
| KR960703619A (ko) | 백신 조성물(vaccine compositions) | |
| DK0762895T3 (da) | Syntetisk vaccine til beskyttelse mod infektion med human immundefektvirus | |
| CY1107560T1 (el) | Ζωντανα εξασθενημενα βακτηρια για χρηση σε εμβολιο | |
| ATE154244T1 (de) | Induzierung eines schutzes gegen virale infektionen | |
| ATE353669T1 (de) | Allergievakzine sowie ihre herstellung | |
| CA2486571A1 (en) | Pharmaceutical composition | |
| RU93058622A (ru) | Композиции на основе фактора лелистада, вакцины, диагностические наборы, способ диагностики | |
| ATE305941T1 (de) | Impfstoff | |
| ATE177010T1 (de) | Immunverstärkung von impfstoffen, besonders von impfstoffen gegen schweinepleuropneumonie |